Previous close | 11.75 |
Open | 11.75 |
Bid | 11.38 x 2900 |
Ask | 11.75 x 1000 |
Day's range | 11.75 - 11.75 |
52-week range | 10.35 - 11.88 |
Volume | |
Avg. volume | 1,245 |
Market cap | 60.999M |
Beta (5Y monthly) | 0.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.21 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) ("Nocturne") and Cognos Therapeutics, Inc. (“Cognos”) today announced the engagement of Chardan, a leading global investment bank, in the role of capital markets advisor to Nocturne in the highly anticipated business combination transaction (the “Business Combination”) with Cognos. This strategic move marks Cognos's journey towards becoming a publicly traded com
To get a sense of who is truly in control of Nocturne Acquisition Corporation ( NASDAQ:MBTC ), it is important to...